Cardio IQ™ Omega-3 and -6 Fatty Acids, Plasma

The Cardio IQ™ Omega-3 and -6 Fatty Acids, Plasma test contains 1 test.

1. Baseline and monitoring of individuals with known CVD (acute and chronic) to determine Rx and compliance. 2. Identify patients with known CVD risk with low omega-3 levels who may be candidates for supplementation/therapy. 3. Monitor patients on omega-3 supplementation/therapy to determine efficacy of treatment. 4. Potential role in risk reduction for non-CVD outcomes-aged related macular degeneration, RA, cancer, etc. (early data).

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Arachidonic Acid (AA), Arachidonic Acid/EPA Ratio, DHA, EPA, Omega-3 Index, Omega-6/omega-3 Ratio, Omega3 and 6 Fatty Acids Plasma, Phospholipid Omega-3 Fatty Acid, Phospholipid Omega-6 Fatty Acid, Polyunsaturated Fatty Acids (PUFAs)